Click here to download a useful tip sheet for patients regarding how to be successful with LACRISERT®. Print out and give to all of your patients receiving a LACRISERT® prescription.
The articles below offer important information about LACRISERT®:
- ARVO Poster: Study of Lacrisert® Dry Eye Insert—Significant Decrease in Ocular Surface Disease Index Eye & Contact Lens Publication: Improvement in Signs and Symptoms of Dry Eye
- Expert Panel on Dry Eye Syndrome—Provides insight into prescribing and counseling patients on optimal use
- Study of Lacrisert® (hydroxypropyl cellulose ophthalmic)—Dry Eye Insert at World Cornea Congress
- Study of Lacrisert® Dry Eye Insert—Published in The Ocular Surface
- Large Study of Lacrisert® Dry Eye Insert Patients—Experience Significant Improvement in Ocular Surface Disease and Quality of Life
The following Web sites* may be helpful in your treatment of Dry Eye:
- Medicare Exemption Form—Medicare Exemption form for Copay Discount for Medicare patients
- MedLinePlus—Provides a brief outline of Dry Eye and how it may affect you
- WebMD—Provides an in-depth explanation of Dry Eye
- eMedicineHealth—Offers detailed information about Dry Eye
- The National Eye Institute—Provides information about various eye diseases and disorders that affect Americans, including Dry Eye
- The Dry Eye Zone—Provides an interactive community offering a discussion forum and other information about Dry Eye
- Dry Eye Yellow Pages—Looking for an eye care professional in your area? The Dry Eye Yellow Pages provides a nationwide list of eye care professionals in one convenient location
Although not specifically focused on Dry Eye, the following links provide helpful information about Sjögren’s syndrome:
- The International Scleroderma Network—Provides information on Sjögren’s syndrome and online support
- Sjogren's World—Offers book reviews, a chat room, and discussion forums
Indications and Usage
LACRISERT® is indicated in patients with moderate to severe Dry Eye syndromes, including keratoconjunctivitis sicca. LACRISERT® is indicated especially in patients who remain symptomatic after an adequate trial of therapy with artificial tear solutions. LACRISERT® is also indicated for patients with exposure keratitis, decreased corneal sensitivity, and recurrent corneal erosions.
Important Safety Information
LACRISERT® is contraindicated in patients who are hypersensitive to hydroxypropyl cellulose. Instructions for inserting and removing LACRISERT® should be carefully followed. If improperly placed, LACRISERT® may result in corneal abrasion. Because LACRISERT® may cause transient blurred vision, patients should be instructed to exercise caution when driving or operating machinery. Patients should be cautioned against rubbing the eye(s) containing LACRISERT®.
The following adverse reactions have been reported, but were in most instances, mild and temporary: transient blurring of vision, ocular discomfort or irritation, matting or stickiness of eyelashes, photophobia, hypersensitivity, eyelid edema, and hyperemia.
*Valeant does not endorse the information contained on these Web sites. When you click on these links, you will be leaving the LACRISERT® Web site.